Showing results (271-280 of 557) with videos related to

Sort By:
Pageof 56
Clinical and Experimental Rheumatology|December 18, 2020
Efficacy and safety of baricitinib in 446 patients with rheumatoid arthritis: a real-life multicentre studyGiacomo Maria Guidelli, Ombretta Viapiana, Nicoletta Luciano, et al.
Expert Review of Clinical Immunology|June 14, 2016
Guillain-Barré syndrome: causes, immunopathogenic mechanisms and treatmentAnil K Jasti, Carlo Selmi, Juan C Sarmiento-Monroy, et al.
Human Genetics|July 11, 2002
Presence of fetal DNA in maternal plasma decades after pregnancyPietro Invernizzi, Maria Luisa Biondi, Pier Maria Battezzati, et al.
Journal of Hepatology|March 30, 2010
Genetic associations in Italian primary sclerosing cholangitis: heterogeneity across Europe defines a critical role for HLA-CJohannes R Hov, Ana Lleo, Carlo Selmi, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 25, 2011
Interdisciplinary evidence-based recommendations for the follow-up of early stage seminomatous testicular germ cell cancer patientsRainer Souchon, Michael Hartmann, Susanne Krege, et al.
Clinical Immunology (Orlando, Fla.)|November 9, 2010
Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosisGaetano Zizzo, Maria De Santis, Silvia Laura Bosello, et al.
Rheumatology (Oxford, England)|October 23, 2019
Cardiopulmonary exercise testing in a combined screening approach to individuate pulmonary arterial hypertension in systemic sclerosisAlessandro Santaniello, Rosa Casella, Marco Vicenzi, et al.
Clinical and Experimental Rheumatology|January 6, 2018
Comparison of the risks of hospitalisation for cardiovascular events in patients with rheumatoid arthritis treated with tocilizumab and etanerceptElena Generali, Greta Carrara, Carlo Selmi, et al.
The Journal of Urology|November 22, 2017
Impact of Primary Tumor Location on Survival from the European Organization for the Research and Treatment of Cancer Advanced Urothelial Cancer StudiesMarco Moschini, Shahrokh F Shariat, Morgan Rouprêt, et al.
Pharmacoeconomics|July 22, 2018
Pembrolizumab for Previously Treated Advanced or Metastatic Urothelial Cancer: An Evidence Review Group Perspective of a NICE Single Technology AppraisalDaniel Gallacher, Xavier Armoiry, Peter Auguste, et al.
Pageof 56